Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panelLynn Kohan, Eugene R. Viscusi, Anuj Aryal et al.|Regional Anesthesia & Pain Medicine|2021Cited by 135
Guidelines for the use of buprenorphine for opioid use disorder in the perioperative settingLynn Kohan, Eugene R. Viscusi, Sudheer Potru et al.|Regional Anesthesia & Pain Medicine|2021Cited by 14
Emergence of xylazine as a public health threat: what does the anesthesiologist need to know for perioperative care?Pawan Solanki, Trent Emerick, Samir Yellapragada et al.|Regional Anesthesia & Pain Medicine|2024Cited by 6
Letter to the editor: Is medetomidine the next perioperative substance of abuse?Aminat Haruna, Trent Emerick, Boris C. Anyama et al.|Regional Anesthesia & Pain Medicine|2025Cited by 2
Response to incorrect application of DSM-5 criteriaLynn Kohan, Eugene R. Viscusi, Anna Dopp et al.|Regional Anesthesia & Pain Medicine|2022Cited by 0